• Patients
  • Careers
  • Contact
Frequency Therapeutics
  • About

    About

    We are a clinical-stage biotechnology company focused on restoring function by developing therapeutics that activate a person’s innate regenerative potential.

    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Clinical Advisory Board
  • Our Science

    Our Science

    Frequency is leading a new category in regenerative medicine designed to activate a person’s innate regenerative potential, within the body, to repair tissue and restore function.

    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs

    Pipeline & Programs

    Developing small-molecule treatments to reverse the debilitating impact of degenerative diseases

    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss

    Hearing Loss

    Hearing loss caused by damage to the sensory cells of the ear impacts hundreds of millions of people globally. Currently there are no FDA-approved treatments to address the underlying condition.

    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media

    Investors & Media

    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • About
    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Clinical Advisory Board
  • Our Science
    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs
    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss
    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media
    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • Patients
  • Careers
  • Contact Us

PCA Regenerative Medicine Advisory Board

Read Bio

Robert S. Langer, ScD

Institute Professor, Massachusetts Institute of Technology

Read Bio

Jeff Karp, PhD

Harvard Medical School; Brigham & Women's Hospital

Read Bio

Steve Haggarty, PhD

Harvard Medical School; Broad Institute of MIT & Harvard

Read Bio

Ralph Mazitschek, PhD

Harvard Medical School; Center for Systems Biology at MGH.

Read Bio

Peter Schultz, PhD

Scripps Research Center

Read Bio

Jeffrey Holt, PhD

Harvard Medical School; Boston Children’s Hospital

Read Bio

Ken Anderson, MD

Dana-Farber Cancer Institute

Read Bio

Xiaolei Yin, PhD

Harvard Medical School; Brigham & Women’s Hospital

Read Bio

John LaMattina, PhD

PureTech Health; Former President of R&D, Pfizer

Read Bio

Sean J. Morrison, PhD

UT Southwestern; Howard Hughes Medical Institute

Read Bio

Siddhartha Mukherjee, MD, DPhil

Columbia University

Read Bio

Amy Wagers, PhD

Harvard University; Joslin Diabetes Center

Read Bio

Robin Franklin, PhD

Wellcome Trust-MRC Cambridge Stem Cell Institute; MS Society Cambridge Centre for Myelin Repair

Read Bio

Sheng Ding, PhD

Gladstone Institute of Cardiovascular Disease; University of California San Francisco

Interested in joining our team? Explore careers

© 2022 Frequency Therapeutics
  • Open Positions
  • Contact
  • Privacy Policy
  • Terms & Conditions